Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsExchange Transfusion, Whole BloodGraft vs Host DiseaseTransplantation, AutologousBlood DonorsBlood TransfusionLiver TransplantationWhole-Body IrradiationTissue DonorsHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalTransplantation ChimeraLeukemiaKidney TransplantationBusulfanHistocompatibility TestingBone and BonesABO Blood-Group SystemBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicHematopoietic Stem CellsCyclophosphamideRecurrenceBone Marrow DiseasesGraft RejectionHeart TransplantationHematopoiesisImmunosuppressive AgentsCombined Modality TherapyTreatment OutcomeStem Cell TransplantationRadiation ChimeraTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLLeukemia, Myeloid, AcuteHematologic NeoplasmsLung TransplantationTime FactorsRemission InductionBone Marrow ExaminationHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionLeukocyte TransfusionAcute DiseaseLiving DonorsOrgan TransplantationLymphoma, Non-HodgkinBone Marrow NeoplasmsRetrospective StudiesBloodHLA AntigensSurvival AnalysisT-LymphocytesSevere Combined ImmunodeficiencyChimeraCyclosporineMyelodysplastic SyndromesColony-Forming Units AssayActuarial AnalysisHematologic DiseasesLymphocyte TransfusionFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilySurvival RateGraft vs Tumor EffectCarmustinePancreas TransplantationCell TransplantationCytomegalovirus InfectionsGraft vs Leukemia EffectIslets of Langerhans TransplantationBone RemodelingPancytopeniaCytarabineCell DifferentiationTransplantationLeukocyte CountCord Blood Stem Cell TransplantationDisease-Free SurvivalGranulocyte Colony-Stimulating FactorMelphalanSpleenMice, Inbred BALB CEtoposideLymphomaMultiple MyelomaAntilymphocyte SerumPeripheral Blood Stem Cell Transplantation